Since a certain number of patients will develop nephritis within the clinical course of IgAV, measuring the concentration of HMGB1 in the urine may be a useful tool in evaluating IgAV patients with nephritis and in making therapeutic approaches. Here, HMGB1 is linked to nephritis.